Loading…

Polydatin impairs mitochondria fitness and ameliorates podocyte injury by suppressing Drp1 expression

Polydatin (PD), a resveratrol glycoside, has been shown to protect renal function in diabetic nephropathy (DN), but the underlying molecular mechanism remains unclear. This study demonstrates that PD stabilize the mitochondrial morphology and attenuate mitochondrial malfunction in both KKAy mice and...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cellular physiology 2017-10, Vol.232 (10), p.2776-2787
Main Authors: Ni, Zheng, Tao, Liang, Xiaohui, Xu, Zelin, Zhao, Jiangang, Liu, Zhao, Song, Weikang, Huo, Hongchao, Xu, Qiujing, Wang, Xin, Li
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4433-3bd9640a725019b5b257a045166a1884d99ac0cb8be04e64092b37c9482a84c03
cites cdi_FETCH-LOGICAL-c4433-3bd9640a725019b5b257a045166a1884d99ac0cb8be04e64092b37c9482a84c03
container_end_page 2787
container_issue 10
container_start_page 2776
container_title Journal of cellular physiology
container_volume 232
creator Ni, Zheng
Tao, Liang
Xiaohui, Xu
Zelin, Zhao
Jiangang, Liu
Zhao, Song
Weikang, Huo
Hongchao, Xu
Qiujing, Wang
Xin, Li
description Polydatin (PD), a resveratrol glycoside, has been shown to protect renal function in diabetic nephropathy (DN), but the underlying molecular mechanism remains unclear. This study demonstrates that PD stabilize the mitochondrial morphology and attenuate mitochondrial malfunction in both KKAy mice and in hyperglycemia (HG)‐induced MPC5 cells. We use Western blot analysis to demonstrate that PD reversed podocyte apoptosis induced by HG via suppressing dynamin‐related protein 1 (Drp1). This effect may depend on the ability of PD to inhibit the generation of cellular reactive oxygen species (ROS). In conclusion, we demonstrate that PD may be therapeutically useful in DN, and that, podocyte apoptosis induced by HG can be reversed by PD through suppressing Drp1 expression. Our findings provide new insights into the pathogenic process of HG‐induced podocyte injury and also identify a new therapeutic target of ROS/Drp1/mitochondrial fission/apoptosis pathway for diabetic nephropathy.
doi_str_mv 10.1002/jcp.25943
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5518182</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1912663436</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4433-3bd9640a725019b5b257a045166a1884d99ac0cb8be04e64092b37c9482a84c03</originalsourceid><addsrcrecordid>eNp1kc1O3DAURq0KVAbaRV-gssQGFmH8m9ibSmigBYRUFu3achwPeJTYwU6AvH1NM0VQidXV1T06-q4-AL5gdIIRIsuN6U8Il4x-AAuMZFWwkpMdsMg3XEjO8B7YT2mDEJKS0o9gjwgqaFXxBbA3oZ0aPTgPXddrFxPs3BDMXfBNdBqu3eBtSlD7BurOti5EPdgE-9AEMw0WOr8Z4wTrCaax72Nmnb-FZ7HH0D7Ne_CfwO5at8l-3s4D8Pv7-a_VRXH988fl6vS6MIxRWtC6kSVDuiIcYVnzmvBKI8ZxWWosBGuk1AaZWtQWMZtJSWpaGckE0YIZRA_At9nbj3VnG2P9EHWr-ug6HScVtFNvL97dqdvwoDjHAguSBUdbQQz3o02D6lwytm21t2FM6jmFqCQhOKOH_6GbMEaf31NYYlKWlNEyU8czZWJIKdr1SxiM1HN5Kpen_paX2a-v07-Q_9rKwHIGHl1rp_dN6mp1Myv_AMQYpTU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1912663436</pqid></control><display><type>article</type><title>Polydatin impairs mitochondria fitness and ameliorates podocyte injury by suppressing Drp1 expression</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><creator>Ni, Zheng ; Tao, Liang ; Xiaohui, Xu ; Zelin, Zhao ; Jiangang, Liu ; Zhao, Song ; Weikang, Huo ; Hongchao, Xu ; Qiujing, Wang ; Xin, Li</creator><creatorcontrib>Ni, Zheng ; Tao, Liang ; Xiaohui, Xu ; Zelin, Zhao ; Jiangang, Liu ; Zhao, Song ; Weikang, Huo ; Hongchao, Xu ; Qiujing, Wang ; Xin, Li</creatorcontrib><description>Polydatin (PD), a resveratrol glycoside, has been shown to protect renal function in diabetic nephropathy (DN), but the underlying molecular mechanism remains unclear. This study demonstrates that PD stabilize the mitochondrial morphology and attenuate mitochondrial malfunction in both KKAy mice and in hyperglycemia (HG)‐induced MPC5 cells. We use Western blot analysis to demonstrate that PD reversed podocyte apoptosis induced by HG via suppressing dynamin‐related protein 1 (Drp1). This effect may depend on the ability of PD to inhibit the generation of cellular reactive oxygen species (ROS). In conclusion, we demonstrate that PD may be therapeutically useful in DN, and that, podocyte apoptosis induced by HG can be reversed by PD through suppressing Drp1 expression. Our findings provide new insights into the pathogenic process of HG‐induced podocyte injury and also identify a new therapeutic target of ROS/Drp1/mitochondrial fission/apoptosis pathway for diabetic nephropathy.</description><identifier>ISSN: 0021-9541</identifier><identifier>EISSN: 1097-4652</identifier><identifier>DOI: 10.1002/jcp.25943</identifier><identifier>PMID: 28383775</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Animals ; Apoptosis ; Apoptosis - drug effects ; Blood Glucose - metabolism ; Cell Line ; Cytoprotection ; Diabetes mellitus ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetes Mellitus, Type 2 - metabolism ; Diabetes Mellitus, Type 2 - pathology ; Diabetic Nephropathies - drug therapy ; Diabetic Nephropathies - etiology ; Diabetic Nephropathies - metabolism ; Diabetic Nephropathies - pathology ; Diabetic nephropathy ; Disease Models, Animal ; Down-Regulation ; Dynamin ; Dynamins - genetics ; Dynamins - metabolism ; dynamin‐related protein 1 ; Fitness ; Glucosides - pharmacology ; Hyperglycemia ; Mice, Inbred C57BL ; Mitochondria ; Mitochondria - drug effects ; Mitochondria - metabolism ; Mitochondria - pathology ; Mitochondrial Dynamics - drug effects ; Nephropathy ; Original ; Original s ; Podocytes - drug effects ; Podocytes - metabolism ; Podocytes - pathology ; polydatin ; Reactive oxygen species ; Reactive Oxygen Species - metabolism ; Renal function ; Resveratrol ; Retarding ; RNA Interference ; Rodents ; Signal Transduction - drug effects ; Stilbenes - pharmacology ; Transfection</subject><ispartof>Journal of cellular physiology, 2017-10, Vol.232 (10), p.2776-2787</ispartof><rights>2017 The Authors. Published by Wiley Periodicals Inc.</rights><rights>2017 The Authors. Journal of Cellular Physiology Published by Wiley Periodicals Inc.</rights><rights>2017 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4433-3bd9640a725019b5b257a045166a1884d99ac0cb8be04e64092b37c9482a84c03</citedby><cites>FETCH-LOGICAL-c4433-3bd9640a725019b5b257a045166a1884d99ac0cb8be04e64092b37c9482a84c03</cites><orcidid>0000-0001-7314-4249</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28383775$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ni, Zheng</creatorcontrib><creatorcontrib>Tao, Liang</creatorcontrib><creatorcontrib>Xiaohui, Xu</creatorcontrib><creatorcontrib>Zelin, Zhao</creatorcontrib><creatorcontrib>Jiangang, Liu</creatorcontrib><creatorcontrib>Zhao, Song</creatorcontrib><creatorcontrib>Weikang, Huo</creatorcontrib><creatorcontrib>Hongchao, Xu</creatorcontrib><creatorcontrib>Qiujing, Wang</creatorcontrib><creatorcontrib>Xin, Li</creatorcontrib><title>Polydatin impairs mitochondria fitness and ameliorates podocyte injury by suppressing Drp1 expression</title><title>Journal of cellular physiology</title><addtitle>J Cell Physiol</addtitle><description>Polydatin (PD), a resveratrol glycoside, has been shown to protect renal function in diabetic nephropathy (DN), but the underlying molecular mechanism remains unclear. This study demonstrates that PD stabilize the mitochondrial morphology and attenuate mitochondrial malfunction in both KKAy mice and in hyperglycemia (HG)‐induced MPC5 cells. We use Western blot analysis to demonstrate that PD reversed podocyte apoptosis induced by HG via suppressing dynamin‐related protein 1 (Drp1). This effect may depend on the ability of PD to inhibit the generation of cellular reactive oxygen species (ROS). In conclusion, we demonstrate that PD may be therapeutically useful in DN, and that, podocyte apoptosis induced by HG can be reversed by PD through suppressing Drp1 expression. Our findings provide new insights into the pathogenic process of HG‐induced podocyte injury and also identify a new therapeutic target of ROS/Drp1/mitochondrial fission/apoptosis pathway for diabetic nephropathy.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Blood Glucose - metabolism</subject><subject>Cell Line</subject><subject>Cytoprotection</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - metabolism</subject><subject>Diabetes Mellitus, Type 2 - pathology</subject><subject>Diabetic Nephropathies - drug therapy</subject><subject>Diabetic Nephropathies - etiology</subject><subject>Diabetic Nephropathies - metabolism</subject><subject>Diabetic Nephropathies - pathology</subject><subject>Diabetic nephropathy</subject><subject>Disease Models, Animal</subject><subject>Down-Regulation</subject><subject>Dynamin</subject><subject>Dynamins - genetics</subject><subject>Dynamins - metabolism</subject><subject>dynamin‐related protein 1</subject><subject>Fitness</subject><subject>Glucosides - pharmacology</subject><subject>Hyperglycemia</subject><subject>Mice, Inbred C57BL</subject><subject>Mitochondria</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - metabolism</subject><subject>Mitochondria - pathology</subject><subject>Mitochondrial Dynamics - drug effects</subject><subject>Nephropathy</subject><subject>Original</subject><subject>Original s</subject><subject>Podocytes - drug effects</subject><subject>Podocytes - metabolism</subject><subject>Podocytes - pathology</subject><subject>polydatin</subject><subject>Reactive oxygen species</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Renal function</subject><subject>Resveratrol</subject><subject>Retarding</subject><subject>RNA Interference</subject><subject>Rodents</subject><subject>Signal Transduction - drug effects</subject><subject>Stilbenes - pharmacology</subject><subject>Transfection</subject><issn>0021-9541</issn><issn>1097-4652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp1kc1O3DAURq0KVAbaRV-gssQGFmH8m9ibSmigBYRUFu3achwPeJTYwU6AvH1NM0VQidXV1T06-q4-AL5gdIIRIsuN6U8Il4x-AAuMZFWwkpMdsMg3XEjO8B7YT2mDEJKS0o9gjwgqaFXxBbA3oZ0aPTgPXddrFxPs3BDMXfBNdBqu3eBtSlD7BurOti5EPdgE-9AEMw0WOr8Z4wTrCaax72Nmnb-FZ7HH0D7Ne_CfwO5at8l-3s4D8Pv7-a_VRXH988fl6vS6MIxRWtC6kSVDuiIcYVnzmvBKI8ZxWWosBGuk1AaZWtQWMZtJSWpaGckE0YIZRA_At9nbj3VnG2P9EHWr-ug6HScVtFNvL97dqdvwoDjHAguSBUdbQQz3o02D6lwytm21t2FM6jmFqCQhOKOH_6GbMEaf31NYYlKWlNEyU8czZWJIKdr1SxiM1HN5Kpen_paX2a-v07-Q_9rKwHIGHl1rp_dN6mp1Myv_AMQYpTU</recordid><startdate>201710</startdate><enddate>201710</enddate><creator>Ni, Zheng</creator><creator>Tao, Liang</creator><creator>Xiaohui, Xu</creator><creator>Zelin, Zhao</creator><creator>Jiangang, Liu</creator><creator>Zhao, Song</creator><creator>Weikang, Huo</creator><creator>Hongchao, Xu</creator><creator>Qiujing, Wang</creator><creator>Xin, Li</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7314-4249</orcidid></search><sort><creationdate>201710</creationdate><title>Polydatin impairs mitochondria fitness and ameliorates podocyte injury by suppressing Drp1 expression</title><author>Ni, Zheng ; Tao, Liang ; Xiaohui, Xu ; Zelin, Zhao ; Jiangang, Liu ; Zhao, Song ; Weikang, Huo ; Hongchao, Xu ; Qiujing, Wang ; Xin, Li</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4433-3bd9640a725019b5b257a045166a1884d99ac0cb8be04e64092b37c9482a84c03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Blood Glucose - metabolism</topic><topic>Cell Line</topic><topic>Cytoprotection</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - metabolism</topic><topic>Diabetes Mellitus, Type 2 - pathology</topic><topic>Diabetic Nephropathies - drug therapy</topic><topic>Diabetic Nephropathies - etiology</topic><topic>Diabetic Nephropathies - metabolism</topic><topic>Diabetic Nephropathies - pathology</topic><topic>Diabetic nephropathy</topic><topic>Disease Models, Animal</topic><topic>Down-Regulation</topic><topic>Dynamin</topic><topic>Dynamins - genetics</topic><topic>Dynamins - metabolism</topic><topic>dynamin‐related protein 1</topic><topic>Fitness</topic><topic>Glucosides - pharmacology</topic><topic>Hyperglycemia</topic><topic>Mice, Inbred C57BL</topic><topic>Mitochondria</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - metabolism</topic><topic>Mitochondria - pathology</topic><topic>Mitochondrial Dynamics - drug effects</topic><topic>Nephropathy</topic><topic>Original</topic><topic>Original s</topic><topic>Podocytes - drug effects</topic><topic>Podocytes - metabolism</topic><topic>Podocytes - pathology</topic><topic>polydatin</topic><topic>Reactive oxygen species</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Renal function</topic><topic>Resveratrol</topic><topic>Retarding</topic><topic>RNA Interference</topic><topic>Rodents</topic><topic>Signal Transduction - drug effects</topic><topic>Stilbenes - pharmacology</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ni, Zheng</creatorcontrib><creatorcontrib>Tao, Liang</creatorcontrib><creatorcontrib>Xiaohui, Xu</creatorcontrib><creatorcontrib>Zelin, Zhao</creatorcontrib><creatorcontrib>Jiangang, Liu</creatorcontrib><creatorcontrib>Zhao, Song</creatorcontrib><creatorcontrib>Weikang, Huo</creatorcontrib><creatorcontrib>Hongchao, Xu</creatorcontrib><creatorcontrib>Qiujing, Wang</creatorcontrib><creatorcontrib>Xin, Li</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cellular physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ni, Zheng</au><au>Tao, Liang</au><au>Xiaohui, Xu</au><au>Zelin, Zhao</au><au>Jiangang, Liu</au><au>Zhao, Song</au><au>Weikang, Huo</au><au>Hongchao, Xu</au><au>Qiujing, Wang</au><au>Xin, Li</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Polydatin impairs mitochondria fitness and ameliorates podocyte injury by suppressing Drp1 expression</atitle><jtitle>Journal of cellular physiology</jtitle><addtitle>J Cell Physiol</addtitle><date>2017-10</date><risdate>2017</risdate><volume>232</volume><issue>10</issue><spage>2776</spage><epage>2787</epage><pages>2776-2787</pages><issn>0021-9541</issn><eissn>1097-4652</eissn><abstract>Polydatin (PD), a resveratrol glycoside, has been shown to protect renal function in diabetic nephropathy (DN), but the underlying molecular mechanism remains unclear. This study demonstrates that PD stabilize the mitochondrial morphology and attenuate mitochondrial malfunction in both KKAy mice and in hyperglycemia (HG)‐induced MPC5 cells. We use Western blot analysis to demonstrate that PD reversed podocyte apoptosis induced by HG via suppressing dynamin‐related protein 1 (Drp1). This effect may depend on the ability of PD to inhibit the generation of cellular reactive oxygen species (ROS). In conclusion, we demonstrate that PD may be therapeutically useful in DN, and that, podocyte apoptosis induced by HG can be reversed by PD through suppressing Drp1 expression. Our findings provide new insights into the pathogenic process of HG‐induced podocyte injury and also identify a new therapeutic target of ROS/Drp1/mitochondrial fission/apoptosis pathway for diabetic nephropathy.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>28383775</pmid><doi>10.1002/jcp.25943</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0001-7314-4249</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9541
ispartof Journal of cellular physiology, 2017-10, Vol.232 (10), p.2776-2787
issn 0021-9541
1097-4652
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5518182
source Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)
subjects Animals
Apoptosis
Apoptosis - drug effects
Blood Glucose - metabolism
Cell Line
Cytoprotection
Diabetes mellitus
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - metabolism
Diabetes Mellitus, Type 2 - pathology
Diabetic Nephropathies - drug therapy
Diabetic Nephropathies - etiology
Diabetic Nephropathies - metabolism
Diabetic Nephropathies - pathology
Diabetic nephropathy
Disease Models, Animal
Down-Regulation
Dynamin
Dynamins - genetics
Dynamins - metabolism
dynamin‐related protein 1
Fitness
Glucosides - pharmacology
Hyperglycemia
Mice, Inbred C57BL
Mitochondria
Mitochondria - drug effects
Mitochondria - metabolism
Mitochondria - pathology
Mitochondrial Dynamics - drug effects
Nephropathy
Original
Original s
Podocytes - drug effects
Podocytes - metabolism
Podocytes - pathology
polydatin
Reactive oxygen species
Reactive Oxygen Species - metabolism
Renal function
Resveratrol
Retarding
RNA Interference
Rodents
Signal Transduction - drug effects
Stilbenes - pharmacology
Transfection
title Polydatin impairs mitochondria fitness and ameliorates podocyte injury by suppressing Drp1 expression
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T18%3A54%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Polydatin%20impairs%20mitochondria%20fitness%20and%20ameliorates%20podocyte%20injury%20by%20suppressing%20Drp1%20expression&rft.jtitle=Journal%20of%20cellular%20physiology&rft.au=Ni,%20Zheng&rft.date=2017-10&rft.volume=232&rft.issue=10&rft.spage=2776&rft.epage=2787&rft.pages=2776-2787&rft.issn=0021-9541&rft.eissn=1097-4652&rft_id=info:doi/10.1002/jcp.25943&rft_dat=%3Cproquest_pubme%3E1912663436%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4433-3bd9640a725019b5b257a045166a1884d99ac0cb8be04e64092b37c9482a84c03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1912663436&rft_id=info:pmid/28383775&rfr_iscdi=true